查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1867511

真菌感染疾病诊断：全球市场份额和排名、总收入和需求预测（2025-2031年）

Fungal Infection Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 119 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球真菌感染疾病诊断市场预计在 2024 年达到 1.25 亿美元，预计到 2031 年将达到 2.81 亿美元，2025 年至 2031 年的复合年增长率为 12.5%。

侵袭性真菌感染疾病（IFD）是由真菌侵入人体组织和血液引起的严重感染疾病，会导致组织损伤、器官功能障碍和发炎反应。 IFD在免疫力缺乏患者中特别常见，例如器官移植受者和癌症患者，发生率高达20%至40%。 IFD是这些患者群体的主要死因之一。为了实现早期诊断和有效治疗，全球大多数医院都采用了非侵入性实验室诊断技术，例如革兰氏阳性菌（G）和革兰氏阴性菌（GM）检测。本报告涵盖了真菌感染疾病诊断中使用的仪器和试剂，并重点介绍了革兰氏阳性菌（G）和革兰氏阴性菌（GM）检测的方法。

侵袭性真菌疾病（IFD）在免疫力缺乏患者中发病率较高，早期诊断仍是一项挑战。目前，G试验和GM试验等非侵入性检测方法已在全球广泛用于真菌感染疾病的早期检测。这些方法检测血清中的真菌抗原，提供了相对快速且非侵入性的诊断工具，尤其适用于免疫抑制患者。然而，儘管这些诊断方法应用广泛，但其敏感性和特异性有限，且对操作人员的技术水平要求较高。此外，一些地区设备和试剂的供应仍然不足，阻碍了其在全球范围内的广泛应用。因此，提高诊断方法的准确性、降低成本并扩大其全球应用仍然是亟待解决的挑战。分子生物学、人工智慧和数位病理学的进步正推动真菌感染疾病诊断领域朝着更高的效率、准确性和智慧化方向发展。例如，将深度学习演算法应用于显微影像，无需染色即可实现快速且准确的检测，从而显着提高诊断效率和准确性。此外，数位病理影像资料资料库的建构为真菌感染疾病的自动化检测和分类提供了丰富的数据支持，促进了该领域的研究和应用。未来，融合人工智慧和分子诊断技术的诊断平台有望成为真菌感染疾病诊断的主流，提供更全面、快速、准确的诊断服务。推动真菌感染疾病诊断技术发展的主要动力是早期诊断和精准治疗的迫切需求。早期诊断和适当治疗对于提高存活率至关重要，尤其对于免疫抑制患者。然而，技术进步面临许多挑战。首先，先进诊断设备和试剂的高成本可能限制其在资源匮乏地区的应用。其次，人工智慧和数位病理技术的引入需要大量高品质数据，但此类数据的获取和共用会带来隐私和伦理方面的挑战。最后，这些技术的广泛应用需要相应的培训和教育，以确保操作人员掌握新技术。因此，解决成本、资料共用和人力资源开发等挑战将是该领域发展的关键。

本报告旨在按地区/国家、类型和应用对全球真菌感染疾病诊断市场进行全面分析，重点关注总收入、市场份额和主要企业的排名。

本报告以收益为准，对真菌感染疾病诊断市场规模、估计值和预测进行了呈现，以2024年为基准年，并涵盖了2020年至2031年的历史数据和预测数据。透过定量和定性分析，我们帮助读者制定真菌感染疾病诊断业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Associates of Cape Cod
  • Bio-Rad
  • IMMY
  • BioMerieux
  • Fujifilm Wako Pure Chemica
  • Era Biology
  • Dynamiker Biotechnology
  • Zhanjiang A&C Biological
  • Xiamen Bioendo Technology
  • Zhanjiang Bokang Marine Biological
  • Fuzhou XinBei Biochemical Industrial
  • Zhuhai DL Biotech
  • Autobio Diagnostics

按类型分類的细分市场

  • 半乳甘露聚醣测试
  • （1->3）- β-D-聚葡萄糖测试

应用领域

  • 医院
  • 考场

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Fungal Infection Diagnosis was estimated to be worth US$ 125 million in 2024 and is forecast to a readjusted size of US$ 281 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.

Invasive fungal disease (IFD) refers to severe infections caused by fungi invading human tissues and bloodstream, leading to tissue damage, organ dysfunction, and inflammatory responses. It is especially prevalent among immunocompromised patients such as organ transplant recipients and cancer patients, with an incidence rate of 20% to 40%, becoming a significant cause of mortality in these populations. To enable early diagnosis and effective treatment, most hospitals worldwide have adopted non-invasive laboratory diagnostic techniques such as the G test and GM test. This report covers the equipment and reagents used for fungal infection diagnosis, specifically focusing on G test and GM test methodologies.

Invasive fungal diseases (IFDs) have a high incidence among immunocompromised patients, and early diagnosis remains challenging. Currently, non-invasive laboratory diagnostic techniques such as the G test and GM test are widely used globally for early detection of fungal infections. These methods detect fungal antigens in serum, providing relatively rapid and non-invasive diagnostic options, especially suitable for immunosuppressed patients. However, despite their widespread adoption, these diagnostic methods still have limitations in sensitivity and specificity, and require high technical expertise from operators. Additionally, in some regions, the availability of equipment and reagents is still insufficient, limiting their global accessibility. Therefore, improving the accuracy of diagnostic methods, reducing costs, and expanding their availability worldwide remain pressing issues.With advancements in molecular biology, artificial intelligence, and digital pathology, the field of fungal infection diagnosis is moving towards higher efficiency, precision, and intelligence. For instance, deep learning algorithms have been applied to automatically classify and identify fungal species in microscopic images, enabling rapid and accurate detection without the need for staining, significantly improving diagnostic efficiency and accuracy. Moreover, the establishment of digital pathology image databases provides rich data support for automated detection and classification of fungal infections, promoting research and application in this field. In the future, integrated diagnostic platforms combining artificial intelligence and molecular diagnostic technologies are expected to become mainstream in fungal infection diagnosis, offering more comprehensive, rapid, and accurate diagnostic services.The primary driver for the development of fungal infection diagnostic technologies is the urgent need for early diagnosis and precise treatment. Especially among immunosuppressed patients, early diagnosis and timely treatment are crucial for improving survival rates. However, technological advancements face several barriers. Firstly, the high cost of advanced diagnostic equipment and reagents may limit their application in resource-limited areas. Secondly, the application of artificial intelligence and digital pathology technologies requires large amounts of high-quality data, and the acquisition and sharing of such data face challenges related to privacy protection and ethical issues. Lastly, the promotion and application of these technologies require corresponding training and education to ensure operators can proficiently master new technologies. Therefore, addressing issues such as cost, data sharing, and personnel training will be key to advancing this field.

This report aims to provide a comprehensive presentation of the global market for Fungal Infection Diagnosis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Fungal Infection Diagnosis by region & country, by Type, and by Application.

The Fungal Infection Diagnosis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fungal Infection Diagnosis.

Market Segmentation

By Company

  • Associates of Cape Cod
  • Bio-Rad
  • IMMY
  • BioMerieux
  • Fujifilm Wako Pure Chemica
  • Era Biology
  • Dynamiker Biotechnology
  • Zhanjiang A&C Biological
  • Xiamen Bioendo Technology
  • Zhanjiang Bokang Marine Biological
  • Fuzhou XinBei Biochemical Industrial
  • Zhuhai DL Biotech
  • Autobio Diagnostics

Segment by Type

  • Galactomannan Test
  • (1->3)-B-D Glucan Test

Segment by Application

  • Hospital
  • Laboratory

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Fungal Infection Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Fungal Infection Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Fungal Infection Diagnosis in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Fungal Infection Diagnosis Product Introduction
  • 1.2 Global Fungal Infection Diagnosis Market Size Forecast (2020-2031)
  • 1.3 Fungal Infection Diagnosis Market Trends & Drivers
    • 1.3.1 Fungal Infection Diagnosis Industry Trends
    • 1.3.2 Fungal Infection Diagnosis Market Drivers & Opportunity
    • 1.3.3 Fungal Infection Diagnosis Market Challenges
    • 1.3.4 Fungal Infection Diagnosis Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Fungal Infection Diagnosis Players Revenue Ranking (2024)
  • 2.2 Global Fungal Infection Diagnosis Revenue by Company (2020-2025)
  • 2.3 Key Companies Fungal Infection Diagnosis Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Fungal Infection Diagnosis Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Fungal Infection Diagnosis
  • 2.6 Fungal Infection Diagnosis Market Competitive Analysis
    • 2.6.1 Fungal Infection Diagnosis Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Fungal Infection Diagnosis Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fungal Infection Diagnosis as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Galactomannan Test
    • 3.1.2 (1->3)-B-D Glucan Test
  • 3.2 Global Fungal Infection Diagnosis Sales Value by Type
    • 3.2.1 Global Fungal Infection Diagnosis Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Fungal Infection Diagnosis Sales Value, by Type (2020-2031)
    • 3.2.3 Global Fungal Infection Diagnosis Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Laboratory
  • 4.2 Global Fungal Infection Diagnosis Sales Value by Application
    • 4.2.1 Global Fungal Infection Diagnosis Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Fungal Infection Diagnosis Sales Value, by Application (2020-2031)
    • 4.2.3 Global Fungal Infection Diagnosis Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Fungal Infection Diagnosis Sales Value by Region
    • 5.1.1 Global Fungal Infection Diagnosis Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Fungal Infection Diagnosis Sales Value by Region (2020-2025)
    • 5.1.3 Global Fungal Infection Diagnosis Sales Value by Region (2026-2031)
    • 5.1.4 Global Fungal Infection Diagnosis Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Fungal Infection Diagnosis Sales Value, 2020-2031
    • 5.2.2 North America Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Fungal Infection Diagnosis Sales Value, 2020-2031
    • 5.3.2 Europe Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Fungal Infection Diagnosis Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Fungal Infection Diagnosis Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Fungal Infection Diagnosis Sales Value, 2020-2031
    • 5.5.2 South America Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Fungal Infection Diagnosis Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Fungal Infection Diagnosis Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Fungal Infection Diagnosis Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Fungal Infection Diagnosis Sales Value, 2020-2031
    • 6.3.2 United States Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Fungal Infection Diagnosis Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Fungal Infection Diagnosis Sales Value, 2020-2031
    • 6.4.2 Europe Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Fungal Infection Diagnosis Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Fungal Infection Diagnosis Sales Value, 2020-2031
    • 6.5.2 China Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Fungal Infection Diagnosis Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Fungal Infection Diagnosis Sales Value, 2020-2031
    • 6.6.2 Japan Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Fungal Infection Diagnosis Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Fungal Infection Diagnosis Sales Value, 2020-2031
    • 6.7.2 South Korea Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Fungal Infection Diagnosis Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Fungal Infection Diagnosis Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Fungal Infection Diagnosis Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Fungal Infection Diagnosis Sales Value, 2020-2031
    • 6.9.2 India Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Fungal Infection Diagnosis Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Associates of Cape Cod
    • 7.1.1 Associates of Cape Cod Profile
    • 7.1.2 Associates of Cape Cod Main Business
    • 7.1.3 Associates of Cape Cod Fungal Infection Diagnosis Products, Services and Solutions
    • 7.1.4 Associates of Cape Cod Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Associates of Cape Cod Recent Developments
  • 7.2 Bio-Rad
    • 7.2.1 Bio-Rad Profile
    • 7.2.2 Bio-Rad Main Business
    • 7.2.3 Bio-Rad Fungal Infection Diagnosis Products, Services and Solutions
    • 7.2.4 Bio-Rad Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Bio-Rad Recent Developments
  • 7.3 IMMY
    • 7.3.1 IMMY Profile
    • 7.3.2 IMMY Main Business
    • 7.3.3 IMMY Fungal Infection Diagnosis Products, Services and Solutions
    • 7.3.4 IMMY Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.3.5 IMMY Recent Developments
  • 7.4 BioMerieux
    • 7.4.1 BioMerieux Profile
    • 7.4.2 BioMerieux Main Business
    • 7.4.3 BioMerieux Fungal Infection Diagnosis Products, Services and Solutions
    • 7.4.4 BioMerieux Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.4.5 BioMerieux Recent Developments
  • 7.5 Fujifilm Wako Pure Chemica
    • 7.5.1 Fujifilm Wako Pure Chemica Profile
    • 7.5.2 Fujifilm Wako Pure Chemica Main Business
    • 7.5.3 Fujifilm Wako Pure Chemica Fungal Infection Diagnosis Products, Services and Solutions
    • 7.5.4 Fujifilm Wako Pure Chemica Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Fujifilm Wako Pure Chemica Recent Developments
  • 7.6 Era Biology
    • 7.6.1 Era Biology Profile
    • 7.6.2 Era Biology Main Business
    • 7.6.3 Era Biology Fungal Infection Diagnosis Products, Services and Solutions
    • 7.6.4 Era Biology Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Era Biology Recent Developments
  • 7.7 Dynamiker Biotechnology
    • 7.7.1 Dynamiker Biotechnology Profile
    • 7.7.2 Dynamiker Biotechnology Main Business
    • 7.7.3 Dynamiker Biotechnology Fungal Infection Diagnosis Products, Services and Solutions
    • 7.7.4 Dynamiker Biotechnology Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Dynamiker Biotechnology Recent Developments
  • 7.8 Zhanjiang A&C Biological
    • 7.8.1 Zhanjiang A&C Biological Profile
    • 7.8.2 Zhanjiang A&C Biological Main Business
    • 7.8.3 Zhanjiang A&C Biological Fungal Infection Diagnosis Products, Services and Solutions
    • 7.8.4 Zhanjiang A&C Biological Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Zhanjiang A&C Biological Recent Developments
  • 7.9 Xiamen Bioendo Technology
    • 7.9.1 Xiamen Bioendo Technology Profile
    • 7.9.2 Xiamen Bioendo Technology Main Business
    • 7.9.3 Xiamen Bioendo Technology Fungal Infection Diagnosis Products, Services and Solutions
    • 7.9.4 Xiamen Bioendo Technology Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Xiamen Bioendo Technology Recent Developments
  • 7.10 Zhanjiang Bokang Marine Biological
    • 7.10.1 Zhanjiang Bokang Marine Biological Profile
    • 7.10.2 Zhanjiang Bokang Marine Biological Main Business
    • 7.10.3 Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Products, Services and Solutions
    • 7.10.4 Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Zhanjiang Bokang Marine Biological Recent Developments
  • 7.11 Fuzhou XinBei Biochemical Industrial
    • 7.11.1 Fuzhou XinBei Biochemical Industrial Profile
    • 7.11.2 Fuzhou XinBei Biochemical Industrial Main Business
    • 7.11.3 Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Products, Services and Solutions
    • 7.11.4 Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Fuzhou XinBei Biochemical Industrial Recent Developments
  • 7.12 Zhuhai DL Biotech
    • 7.12.1 Zhuhai DL Biotech Profile
    • 7.12.2 Zhuhai DL Biotech Main Business
    • 7.12.3 Zhuhai DL Biotech Fungal Infection Diagnosis Products, Services and Solutions
    • 7.12.4 Zhuhai DL Biotech Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Zhuhai DL Biotech Recent Developments
  • 7.13 Autobio Diagnostics
    • 7.13.1 Autobio Diagnostics Profile
    • 7.13.2 Autobio Diagnostics Main Business
    • 7.13.3 Autobio Diagnostics Fungal Infection Diagnosis Products, Services and Solutions
    • 7.13.4 Autobio Diagnostics Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Autobio Diagnostics Recent Developments

8 Industry Chain Analysis

  • 8.1 Fungal Infection Diagnosis Industrial Chain
  • 8.2 Fungal Infection Diagnosis Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Fungal Infection Diagnosis Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Fungal Infection Diagnosis Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Fungal Infection Diagnosis Market Trends
  • Table 2. Fungal Infection Diagnosis Market Drivers & Opportunity
  • Table 3. Fungal Infection Diagnosis Market Challenges
  • Table 4. Fungal Infection Diagnosis Market Restraints
  • Table 5. Global Fungal Infection Diagnosis Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Fungal Infection Diagnosis Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Fungal Infection Diagnosis Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Fungal Infection Diagnosis Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Fungal Infection Diagnosis
  • Table 10. Global Fungal Infection Diagnosis Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fungal Infection Diagnosis as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Fungal Infection Diagnosis Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Fungal Infection Diagnosis Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Fungal Infection Diagnosis Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Fungal Infection Diagnosis Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Fungal Infection Diagnosis Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Fungal Infection Diagnosis Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Fungal Infection Diagnosis Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Fungal Infection Diagnosis Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Fungal Infection Diagnosis Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Fungal Infection Diagnosis Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Fungal Infection Diagnosis Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Fungal Infection Diagnosis Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Fungal Infection Diagnosis Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Fungal Infection Diagnosis Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Fungal Infection Diagnosis Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Fungal Infection Diagnosis Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Fungal Infection Diagnosis Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Fungal Infection Diagnosis Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Associates of Cape Cod Basic Information List
  • Table 32. Associates of Cape Cod Description and Business Overview
  • Table 33. Associates of Cape Cod Fungal Infection Diagnosis Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Associates of Cape Cod (2020-2025)
  • Table 35. Associates of Cape Cod Recent Developments
  • Table 36. Bio-Rad Basic Information List
  • Table 37. Bio-Rad Description and Business Overview
  • Table 38. Bio-Rad Fungal Infection Diagnosis Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Bio-Rad (2020-2025)
  • Table 40. Bio-Rad Recent Developments
  • Table 41. IMMY Basic Information List
  • Table 42. IMMY Description and Business Overview
  • Table 43. IMMY Fungal Infection Diagnosis Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Fungal Infection Diagnosis Business of IMMY (2020-2025)
  • Table 45. IMMY Recent Developments
  • Table 46. BioMerieux Basic Information List
  • Table 47. BioMerieux Description and Business Overview
  • Table 48. BioMerieux Fungal Infection Diagnosis Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Fungal Infection Diagnosis Business of BioMerieux (2020-2025)
  • Table 50. BioMerieux Recent Developments
  • Table 51. Fujifilm Wako Pure Chemica Basic Information List
  • Table 52. Fujifilm Wako Pure Chemica Description and Business Overview
  • Table 53. Fujifilm Wako Pure Chemica Fungal Infection Diagnosis Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Fujifilm Wako Pure Chemica (2020-2025)
  • Table 55. Fujifilm Wako Pure Chemica Recent Developments
  • Table 56. Era Biology Basic Information List
  • Table 57. Era Biology Description and Business Overview
  • Table 58. Era Biology Fungal Infection Diagnosis Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Era Biology (2020-2025)
  • Table 60. Era Biology Recent Developments
  • Table 61. Dynamiker Biotechnology Basic Information List
  • Table 62. Dynamiker Biotechnology Description and Business Overview
  • Table 63. Dynamiker Biotechnology Fungal Infection Diagnosis Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Dynamiker Biotechnology (2020-2025)
  • Table 65. Dynamiker Biotechnology Recent Developments
  • Table 66. Zhanjiang A&C Biological Basic Information List
  • Table 67. Zhanjiang A&C Biological Description and Business Overview
  • Table 68. Zhanjiang A&C Biological Fungal Infection Diagnosis Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Zhanjiang A&C Biological (2020-2025)
  • Table 70. Zhanjiang A&C Biological Recent Developments
  • Table 71. Xiamen Bioendo Technology Basic Information List
  • Table 72. Xiamen Bioendo Technology Description and Business Overview
  • Table 73. Xiamen Bioendo Technology Fungal Infection Diagnosis Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Xiamen Bioendo Technology (2020-2025)
  • Table 75. Xiamen Bioendo Technology Recent Developments
  • Table 76. Zhanjiang Bokang Marine Biological Basic Information List
  • Table 77. Zhanjiang Bokang Marine Biological Description and Business Overview
  • Table 78. Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Zhanjiang Bokang Marine Biological (2020-2025)
  • Table 80. Zhanjiang Bokang Marine Biological Recent Developments
  • Table 81. Fuzhou XinBei Biochemical Industrial Basic Information List
  • Table 82. Fuzhou XinBei Biochemical Industrial Description and Business Overview
  • Table 83. Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Fuzhou XinBei Biochemical Industrial (2020-2025)
  • Table 85. Fuzhou XinBei Biochemical Industrial Recent Developments
  • Table 86. Zhuhai DL Biotech Basic Information List
  • Table 87. Zhuhai DL Biotech Description and Business Overview
  • Table 88. Zhuhai DL Biotech Fungal Infection Diagnosis Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Zhuhai DL Biotech (2020-2025)
  • Table 90. Zhuhai DL Biotech Recent Developments
  • Table 91. Autobio Diagnostics Basic Information List
  • Table 92. Autobio Diagnostics Description and Business Overview
  • Table 93. Autobio Diagnostics Fungal Infection Diagnosis Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Autobio Diagnostics (2020-2025)
  • Table 95. Autobio Diagnostics Recent Developments
  • Table 96. Key Raw Materials Lists
  • Table 97. Raw Materials Key Suppliers Lists
  • Table 98. Fungal Infection Diagnosis Downstream Customers
  • Table 99. Fungal Infection Diagnosis Distributors List
  • Table 100. Research Programs/Design for This Report
  • Table 101. Key Data Information from Secondary Sources
  • Table 102. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Fungal Infection Diagnosis Product Picture
  • Figure 2. Global Fungal Infection Diagnosis Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Fungal Infection Diagnosis Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Fungal Infection Diagnosis Report Years Considered
  • Figure 5. Global Fungal Infection Diagnosis Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Fungal Infection Diagnosis Revenue in 2024
  • Figure 7. Fungal Infection Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Galactomannan Test Picture
  • Figure 9. (1->3)-B-D Glucan Test Picture
  • Figure 10. Global Fungal Infection Diagnosis Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Fungal Infection Diagnosis Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Hospital
  • Figure 13. Product Picture of Laboratory
  • Figure 14. Global Fungal Infection Diagnosis Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Fungal Infection Diagnosis Sales Value Market Share by Application, 2024 & 2031
  • Figure 16. North America Fungal Infection Diagnosis Sales Value (2020-2031) & (US$ Million)
  • Figure 17. North America Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031
  • Figure 18. Europe Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 19. Europe Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031
  • Figure 20. Asia Pacific Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 21. Asia Pacific Fungal Infection Diagnosis Sales Value by Region (%), 2024 VS 2031
  • Figure 22. South America Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. South America Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031
  • Figure 24. Middle East & Africa Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. Middle East & Africa Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031
  • Figure 26. Key Countries/Regions Fungal Infection Diagnosis Sales Value (%), (2020-2031)
  • Figure 27. United States Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. United States Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
  • Figure 29. United States Fungal Infection Diagnosis Sales Value by Application (%), 2024 VS 2031
  • Figure 30. Europe Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Europe Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
  • Figure 32. Europe Fungal Infection Diagnosis Sales Value by Application (%), 2024 VS 2031
  • Figure 33. China Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. China Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
  • Figure 35. China Fungal Infection Diagnosis Sales Value by Application (%), 2024 VS 2031
  • Figure 36. Japan Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. Japan Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
  • Figure 38. Japan Fungal Infection Diagnosis Sales Value by Application (%), 2024 VS 2031
  • Figure 39. South Korea Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. South Korea Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
  • Figure 41. South Korea Fungal Infection Diagnosis Sales Value by Application (%), 2024 VS 2031
  • Figure 42. Southeast Asia Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. Southeast Asia Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
  • Figure 44. Southeast Asia Fungal Infection Diagnosis Sales Value by Application (%), 2024 VS 2031
  • Figure 45. India Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. India Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
  • Figure 47. India Fungal Infection Diagnosis Sales Value by Application (%), 2024 VS 2031
  • Figure 48. Fungal Infection Diagnosis Industrial Chain
  • Figure 49. Fungal Infection Diagnosis Manufacturing Cost Structure
  • Figure 50. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 51. Bottom-up and Top-down Approaches for This Report
  • Figure 52. Data Triangulation
  • Figure 53. Key Executives Interviewed